6533b7d4fe1ef96bd1261ed5
RESEARCH PRODUCT
Algorithms for the Automated Analysis of Age-Related Macular Degeneration Biomarkers on Optical Coherence Tomography: A Systematic Review
Thomas SchultzRobert P. FingerMaximilian W. M. WintergerstFrank G. HolzSteffen Schmitz-valckenbergAlexander K. SchusterNorbert PfeifferJohannes Birtelsubject
automated image analysisBiomedical EngineeringCADReviewDrusen030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineOptical coherence tomographyAge relatedmedicineGrading (tumors)age-related macular degenerationoptical coherence tomographymedicine.diagnostic_testbusiness.industryMacular degenerationmedicine.diseaseeye diseasesOphthalmologySystematic review030221 ophthalmology & optometryBiomarker (medicine)sense organsbusinessAlgorithmdescription
PURPOSE To assess the quality of optical coherence tomography (OCT) grading algorithms for retinal biomarkers of age-related macular degeneration (AMD). METHODS Following a systematic review of the literature data on detection and quantification of AMD retinal biomarkers by available algorithms were extracted and descriptively synthesized. Algorithm quality was assessed using a modified version of the Quality Assessment of Diagnostic Accuracy Studies 2 checklist with a focus on accuracy against established reference standards and risk of bias. RESULTS Thirty five studies reporting computer-aided diagnosis (CAD) tools for qualitative analysis or algorithms for quantitative analysis were identified. Compared with manual assessment in reference standards correlation coefficients ranged from 0.54 to 0.97 for drusen, 0.80 to 0.98 for geographic atrophy (GA), and 0.30 to 0.98 for intra- or subretinal fluid and pigment epithelial detachment (PED) detection by automated algorithms. CAD tools achieved area under the curve (AUC) values of 0.94 to 0.99, sensitivity of 0.90 to 1.00, and specificity of 0.89 to 0.92. CONCLUSIONS Automated analysis of AMD biomarkers on OCT is promising. However, most of the algorithm validation was performed in preselected patients, exhibiting the targeted biomarker only. In addition, type and quality of reported algorithm validation varied substantially. TRANSLATIONAL RELEVANCE The development of algorithms for combined, simultaneous analysis of multiple AMD biomarkers including AMD staging and the agreement on standardized validation procedures would be of considerable translational value for the clinician and the clinical researcher.
year | journal | country | edition | language |
---|---|---|---|---|
2017-07-01 | Translational Vision Science & Technology |